Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-9450 in Adults With NASH
NCT00740610Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Countries
- 2
01
Overview
A Phase 2 trial of nivocasan in Nonalcoholic steatohepatitis (NASH), sponsored by Gilead Sciences. Started Aug 2008; status: completed.
02
Drugs
nivocasan
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00740610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740610.